From: Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
(N = 402) | |
---|---|
Mean age, years (SD) | 29.7 (9.4) |
Median age of diagnosis, years (IQR) | 1.5 (8) |
Gender, % Female (N) | 48.8 (196) |
Race, % Caucasian (N) | 94.3 (379) |
Ethnicity, % Hispanic (N) | 1.9 (7) |
f508del status | |
Homozygous, % (N) | 52.4 (200) |
Heterozygous, % (N) | 39.0 (149) |
Other, % (N) | 8.6 (33) |
CFTR Mutation Classification ad | |
Minimal, % (N) | 71.7 (274) |
Residual, % (N) | 10.7 (41) |
Unclassified, % (N) | 17.5 (67) |
FEV1, % predicted (SD)d | 63.5 (26.0) |
Co-morbidities | |
CF-related diabetes bd, % (N) | 28.0 (109) |
Pancreatic insufficiency cd, % (N) | 86.3 (308) |
Inhaled Antibiotic Used | 49.5 (147) |
Microbiology | |
Any form of Pseudomonas isolated, % (N) | 64.2 (238) |
Mucoid Pseudomonas phenotype, % (N) | 48.0 (178) |